Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in Worldwide (Relatlimab, Nivolumab, Bevacizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +62 more
Feb 1, 2023

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Germany, United States (Regorafenib(Stivarga, BAY73-4506), Pembrolizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +6 more
Aug 15, 2022

Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • San Francisco, California
  • +8 more
Jul 19, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

Glycotest™ HCC Panel vs AFP for Detection of Early-stage

Recruiting
  • Carcinoma, Hepatocellular
  • Cirrhosis, Liver
    • Los Angeles, California
    • +19 more
    Mar 14, 2022

    Carcinoma, Hepatocellular Trial in Worldwide (CC-122, Nivolumab)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Los Angeles, California
    • +13 more
    Apr 16, 2021

    Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

    Completed
    • Carcinoma, Hepatocellular
    • Refametinib (BAY86-9766)
    • Washington, District of Columbia
    • +57 more
    Apr 6, 2021

    Carcinoma, Hepatocellular Trial in Worldwide (LY2157299, Sorafenib, Ramucirumab)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Fayetteville, Arkansas
    • +39 more
    Dec 21, 2020

    Carcinoma, Hepatocellular Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Regorafenib (Stivarga, BAY73-4506)
    • Placebo
    • Los Angeles, California
    • +146 more
    Aug 11, 2020

    Carcinoma, Hepatocellular Trial in Worldwide (Placebo, GC33)

    Completed
    • Carcinoma, Hepatocellular
    • Los Angeles, California
    • +56 more
    Apr 1, 2020

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Erlotinib (Tarceva), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • +2 more
    • San Francisco, California
    • +126 more
    May 16, 2019

    Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Nexavar (Sorafenib, BAY43-9006)
    • Placebo
    • Birmingham, Alabama
    • +198 more
    Jul 11, 2018

    Carcinoma, Hepatocellular Trial in United States (RO7070179)

    Completed
    • Carcinoma, Hepatocellular
    • Indianapolis, Indiana
    • +6 more
    Feb 13, 2018

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • Placebo
    • La Jolla, California
    • +106 more
    Jul 18, 2017

    Carcinoma, Hepatocellular Trial in Worldwide (Onartuzumab, Sorafenib)

    Completed
    • Carcinoma, Hepatocellular
    • Sarasota, Florida
    • +9 more
    Nov 1, 2016

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • Placebo
    • Phoenix, Arizona
    • +177 more
    Oct 24, 2014

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin, Doxorubicin/Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin
    • Doxorubicin/Placebo
    • Birmingham, Alabama
    • +27 more
    Oct 24, 2014

    Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006))

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • Los Angeles, California
    • +22 more
    Mar 26, 2014

    Carcinoma, Hepatocellular Trial in United States (Thymalfasin (thymosin alpha-1), Trans arterial chemoembolization (TACE))

    Completed
    • Carcinoma, Hepatocellular
    • Thymalfasin (thymosin alpha-1)
    • Trans arterial chemoembolization (TACE)
    • San Francisco, California
    • +4 more
    Jan 8, 2008

    Carcinoma, Hepatocellular Trial in Worldwide (MTC-DOX for Injection)

    Terminated
    • Carcinoma, Hepatocellular
    • MTC-DOX for Injection
    • Long Beach, California
    • +28 more
    Jun 23, 2005